Abstract:Ghrelin is a novel 28-amino acid peptide with an n-octanoyl ester in the serine 3 that has recently been discovered in rat and human gastrointestinal tract, as an endogenous ligand for growth hormone (GH) secretagogue receptor 1. Ghrelin is produced and stored in granules of the special neuroendocrine cells (A-like cells), located mainly in oxyntic mucosa 2. Ghrelin stimulates GH release and induces a positive energy balance by stimulating food intake and decreasing fat use 3. Ghrelin also has numerous peripheral actions including direct effects on exocrine and endocrine pancreatic functions, carbohydrate metabolism, gastric secretion, stomach motility, and sleep 4. Recently, some authors revealed that administration of ghrelin during reperfusion had protective effects on myocardial ischemia reperfusion injury, including reduced ischemic volume, improvements in coronary flow, and attenuation of lipid peroxidation in a rat model 5. But the exact effect of ghrelin on focal cerebral ischemia reperfusion and the mechanism underlying it are still unknown. Focal cerebral ischemia in adult male Sprague-Dawley rats (weighing 250–280 g) was induced by MCAO (middle cerebral artery occlusion) for 90 min with an intraluminal filament according to the method previously described by Longa 6. Rat ghrelin was administered intraperitoneally (160 μg/kg) 30 min before MCAO and at the beginning of reperfusion. Brain samples were obtained 24 h after MCAO. In this study, we demonstrated that systemic administration of ghrelin significantly reduced infarct volumes from MCAO (data shown in Figure 1A). The protective effect of ghrelin on cell apoptosis and neuronal degeneration after ischemia reperfusion injury was evaluated by TUNEL and Fluoro-Jade B staining, a kind of polyanionic fluorescein derivative that specifically bound to degenerating neurons. In ghrelin-treated group, the number of TUNEL-positive cells and degenerating neurons in the peri-infarct area decreased significantly (Figure 1B,C). Given the fact that ghrelin can pass through the blood–brain barrier 7, these findings suggest that peripherally administered ghrelin enters the brain parenchyma and exerts neuroprotective effects on cerebral ischemia reperfusion. The inhibitive effect of ghrelin on apoptosis was supposed to be related to the activation of PI3K/AKT signaling pathway by the phosphoralation of Akt in an endothelial cell injury 8. Reactive oxygen species (ROS) have been implicated in the pathogenesis of cerebral ischemia reperfusion injury 9. These oxygen-free radicals are directly toxic to neurons and initiate a free radical-mediated cascade causing neuronal damage. To assess the effect of ghrelin on ROS, we evaluated the production of superoxide anion, an important reactive oxygen species (ROS) using DHE (dihydroethidium). In this study, we found superoxide anion production was enhanced after reperfusion, and ghrelin treatment could attenuate it (Figure 2). These might be related to the mechanism that ghrelin could inhibit NADPH oxidase activation and reduce ROS production 10. In summary, we have demonstrated that peripheral administration of ghrelin could protect neurons from ischemic injury caused by MCAO. The protective effects of ghrelin appear to be related with an inhibition of apoptosis and oxidative stress. Our results suggest that ghrelin can function as a neuroprotective agent, and administration of ghrelin may be a novel therapeutic strategy for the treatment of ischemic stroke. This study was supported by National Natural Sciences Foundation of China (30801183), Key Clinical Disciplines Program of Chinese Health Ministry and Grants of Health Bureau of Zhejiang Province (2012).

Ghrelin Prevents Neuronal Apoptosis and Cognitive Impairments in Sepsis-Associated Encephalopathy

Ghrelin Inhibits Proinflammatory Responses and Prevents Cognitive Impairment in Septic Rats.

Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats.

Ghrelin protects small intestinal epithelium against sepsis-induced injury by enhancing the autophagy of intestinal epithelial cells.

Ghrelin Attenuates Secondary Brain Injury Following Intracerebral Hemorrhage by Inhibiting NLRP3 Inflammasome Activation and Promoting Nrf2/ARE Signaling Pathway in Mice

Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis

Ghrelin Attenuated Cerebral Ischemia Reperfusion Injury in Rats

Ghrelin prevents lethality in a rat endotoxemic model through central effects on the vagal pathway and adenosine A2B signaling : Brain ghrelin and anti-septic action

Ghrelin alleviates early brain injury after subarachnoid hemorrhage via the PI3K/Akt signaling pathway.

Ghrelin Alleviates Intestinal Dysfunction in Sepsis Through the KLF4/MMP2 Regulatory Axis by Activating SIRT1

Ghrelin Protects Mice Against Endotoxemia-Induced Acute Kidney Injury.

The Inhibitory Effect of Ghrelin on Sepsis-Induced Inflammation is Mediated by the MAPK Phosphatase-1.

Ghrelin inhibits inflammatory response and apoptosis of myocardial injury in septic rats through JAK/STAT signaling pathway

Γ-secretase Inhibitor DAPT Prevents Neuronal Death and Memory Impairment in Sepsis Associated Encephalopathy in Septic Rats.

Ghrelin Inhibits Sympathetic Nervous Activity in Sepsis.

Ghrelin attenuates the inflammatory response induced by experimental endotoxemia in mice

Ghrelin Upregulates PepT1 Activity in the Small Intestine Epithelium of Rats with Sepsis.

Ghrelin Promotes Cortical Neurites Growth in Late Stage after Oxygen-Glucose Deprivation/Reperfusion Injury

Ghrelin/GHSR Axis Induced M2 Macrophage and Alleviated Intestinal Barrier Dysfunction in a Sepsis Rat Model by Inactivating E2F1/NF- κ B Signaling

Effects of Early Administration of Insulin-Like Growth Factor-1 on Cognitive Function in Septic Encephalopathy

Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways.